Recent Advances in Reprogramming Strategy of Tumor Microenvironment for Rejuvenating Photosensitizers-Mediated Photodynamic Therapy

Small. 2024 Apr;20(16):e2305708. doi: 10.1002/smll.202305708. Epub 2023 Nov 28.

Abstract

Photodynamic therapy (PDT) has recently been considered a potential tumor therapy due to its time-space specificity and non-invasive advantages. PDT can not only directly kill tumor cells by using cytotoxic reactive oxygen species but also induce an anti-tumor immune response by causing immunogenic cell death of tumor cells. Although it exhibits a promising prospect in treating tumors, there are still many problems to be solved in its practical application. Tumor hypoxia and immunosuppressive microenvironment seriously affect the efficacy of PDT. The hypoxic and immunosuppressive microenvironment is mainly due to the abnormal vascular matrix around the tumor, its abnormal metabolism, and the influence of various immunosuppressive-related cells and their expressed molecules. Thus, reprogramming the tumor microenvironment (TME) is of great significance for rejuvenating PDT. This article reviews the latest strategies for rejuvenating PDT, from regulating tumor vascular matrix, interfering with tumor cell metabolism, and reprogramming immunosuppressive related cells and factors to reverse tumor hypoxia and immunosuppressive microenvironment. These strategies provide valuable information for a better understanding of the significance of TME in PDT and also guide the development of the next-generation multifunctional nanoplatforms for PDT.

Keywords: photodynamic therapy; photosensitizers‐mediated multifunctional nanoplatform; tumor microenvironment reprogramming.

Publication types

  • Review

MeSH terms

  • Cell Line, Tumor
  • Humans
  • Hypoxia
  • Nanoparticles*
  • Neoplasms*
  • Photochemotherapy*
  • Photosensitizing Agents
  • Reactive Oxygen Species
  • Tumor Microenvironment

Substances

  • Photosensitizing Agents
  • Reactive Oxygen Species